Syngenta delists Devgen following squeeze-out process

Syngenta has delisted hybrid rice and RNA technology firm Devgen (Ghent, Belgium) from the NYSE Euronext Brussels exchange, the company announced today. Syngenta secured 94% of the shares of Devgen last December during a €403-million ($526.7 million) public takeover bid. The original deal had been announced in September 2012. Syngenta, following a squeeze-out process that closed yesterday, holds 100% of Devgen's shares. Prior to the opening of the squeeze-out on 6 February, 98.32% of Devgen shares had been tendered to Syngenta. Payment for the shares and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers